Marathon Trading Investment Management LLC Has $430,000 Stock Position in Teladoc Health, Inc. $TDOC

Key Points

• Marathon Trading Investment Management LLC increased its stake in Teladoc Health by 350% in the first quarter, now owning 54,000 shares worth approximately $430,000.
• Teladoc Health reported a loss of ($0.19) EPS for the last quarter, surpassing analysts' expectations, with revenue of $631.90 million.
• The current consensus rating for Teladoc Health among analysts is "Hold," with a target price of $9.76.

Marathon Trading Investment Management LLC increased its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 350.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 54,000 shares of the health services provider's stock after purchasing an additional 42,000 shares during the quarter. Marathon Trading Investment Management LLC's holdings in Teladoc Health were worth $430,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. raised its holdings in Teladoc Health by 60.8% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider's stock worth $316,000 after purchasing an additional 15,030 shares during the period. Golden State Wealth Management LLC increased its position in shares of Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after buying an additional 1,690 shares in the last quarter. Wedmont Private Capital raised its stake in Teladoc Health by 20.3% during the 1st quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider's stock worth $117,000 after buying an additional 2,715 shares during the period. Geode Capital Management LLC lifted its holdings in Teladoc Health by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock worth $35,894,000 after acquiring an additional 22,664 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its stake in Teladoc Health by 22.1% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock valued at $134,000 after acquiring an additional 2,662 shares during the period. 76.82% of the stock is owned by institutional investors.

Insider Buying and Selling at Teladoc Health

In other news, insider Carlos Nueno sold 3,958 shares of the business's stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $27,151.88. Following the completion of the sale, the insider owned 17,645 shares in the company, valued at $121,044.70. The trade was a 18.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Adam C. Vandervoort sold 5,808 shares of the stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $39,842.88. Following the transaction, the insider owned 69,773 shares in the company, valued at $478,642.78. The trade was a 7.68% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 18,656 shares of company stock worth $128,189 over the last ninety days. Insiders own 0.58% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on TDOC shares. Citigroup dropped their price target on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating on the stock in a research report on Friday, April 25th. Stifel Nicolaus lowered their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research report on Thursday, May 1st. Evercore ISI raised their price objective on shares of Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a report on Wednesday, July 9th. Canaccord Genuity Group reduced their target price on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a research note on Thursday, May 1st. Finally, Jefferies Financial Group lowered their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a report on Monday, April 21st. Twelve equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $9.76.

Teladoc Health Stock Performance

Shares of Teladoc Health stock traded up $0.21 during trading on Friday, hitting $7.51. 5,729,024 shares of the stock were exchanged, compared to its average volume of 7,926,855. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70. The company has a fifty day moving average price of $7.72 and a 200-day moving average price of $8.30. The stock has a market capitalization of $1.33 billion, a price-to-earnings ratio of -6.31 and a beta of 1.76. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%. The firm had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. During the same quarter in the previous year, the business earned ($0.38) earnings per share. The business's revenue was down 1.6% compared to the same quarter last year. As a group, equities analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.